Therapy Areas: Infectious Diseases
RedHill Biopharma advancing opaganib options for Ebola outbreak
4 June 2026 - Specialty biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) announced on Wednesday that it is actively discussing potential collaborations for advancement of its investigatio...
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases
26 May 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Tuesday that it will present new preclinical data on its TG-MVA prophylactic vaccine candidates against mpox at the Wor...
Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment
21 May 2026 - South Korea-based biotechnology company Hyundai Bioscience announced on Wednesday that XAFTY has a strong likelihood of being able to treat Ebola and Hantavirus due to its low IC50 (50% ...
Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses
24 April 2026 - Canadian pharmaceutical company Apotex Inc and Cumberland Pharmaceuticals Inc, a US-based specialty pharmaceutical company, announced on Thursday that they have entered into a strategi...
Ondine Biomedical abstracts selected for 2026 World Congress on Infectious Diseases
22 April 2026 - Ondine Biomedical Inc (LON: OBI), a provider of photodisinfection-based therapies, announced on Wednesday that it has secured acceptance of two abstracts for poster presentation at the...
26Health acquires Optimal Integrative Care
16 March 2026 - 26Health, a provider of primary care and mental health services in the Southeast USA, announced on Friday that it has acquired Optimal Integrative Care, a medical practice in the West ...